Fujian Cancer Hospital
3 clinical trials · 3 recruiting · OTHER_GOV
Trials by Fujian Cancer Hospital
RECRUITINGPhase 2 / Phase 3NCT05699655
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann...
To evaluate the clinical efficacy and safety of Tislelizumab combined with apatinib mesylate, oxaliplatin plus S1 Vs oxaliplatin plus S1.
Sponsor: Fujian Cancer HospitalEnrolling: 1301 location
Immunotherapy Gastrict Cancer
RECRUITINGPhase 2NCT06463834
A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
This study is aimed to evaluate the efficacy and safety of sintilimab combined with chemotherapy (docetaxel+cisplatin+5-fluorouracil, DCF) in neoadjuvant treatment of locally...
Sponsor: Fujian Cancer HospitalEnrolling: 301 location
Esophageal Squamous Cell Carcinoma
RECRUITINGNCT07142122
Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the...
This prospective, single-center, randomized, controlled, non-inferiority clinical trial aims to compare the safety and postoperative quality of life of early upper gastric cancer...
Sponsor: Fujian Cancer HospitalEnrolling: 761 location
Gastric Cancer